Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine

    Sep 18, 2017, 10:26 AM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Sep 18, 2017 - Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision MedicineSan Francisco, CA - September 18, 2017Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing investor Data Collective (DCVC) and new investor Ascension Ventures, and participation from existing and new investors iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and Stanford
    Full story
  • Earlham Institute Presents Sequence Alignment Using Optalysys’ Optical Correlator Computing System

    Sep 18, 2017, 09:35 AM by Michael Croft

    Bio-IT World | 2017 Best Practices Awards | The Earlham Institute are working with Optalysys to apply Optalysys’ optical computing system to life science applications. The first release of the computing system is scheduled for early 2018, which both organizations say will be capable of performing a number of different DNA-based local sequence alignment applications.

    Full story
  • Demand for genetic testing drives growth for award winning Elucigene diagnostics

    Sep 15, 2017, 04:47 AM by Michael Croft
    MANCHESTER, UNITED KINGDOM - Sep 15, 2017 - Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics
    Full story
  • Oxford Genetics Supports Significant Growth with New U.S. Office

    Sep 14, 2017, 14:54 PM by Michael Croft
    BOSTON, MA, UNITED STATES - Sep 12, 2017 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has announced that it has opened its first U
    Full story
  • Recipharm and Kancera collaborate to manufacture clinical trial supply

    Sep 14, 2017, 14:48 PM by Michael Croft
    SOLNA, SWEDEN - Sep 14, 2017 - Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567
    Full story
  • Moderna Ends “Venture” Experiment, Dissolves Four Startups

    Sep 14, 2017, 10:03 AM by Michael Croft
    Xconomy | Moderna Therapeutics announced today that it is ending the experiment to hatch startups as wholly-owned subsidaries, bringing all their experimental drugs back into the Moderna nest.
    Full story
  • Kyowa Hakko Kirin Joins Certara’s Simcyp Consortium

    Sep 13, 2017, 09:22 AM by Michael Croft
    PRINCETON, NJ - Sep 13, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin Co
    Full story
  • Brainin Joins WuXi NextCODE, Prioritizes Actionability Of Genome

    Sep 13, 2017, 09:00 AM by Michael Croft

    Bio-IT World | WuXi NextCODE today announced the appointment of Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.

    Full story
  • BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource

    Sep 13, 2017, 02:12 AM by Michael Croft
    BASEL, SWITZERLAND - Sep 13, 2017 -  BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data
    Full story
  • Maine Technology Institute Funds MDI Biological Laboratory Scientist

    Sep 12, 2017, 16:11 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Sep 12, 2017 - The Maine Technology Institute (MTI) has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans
    Full story
  • IBM Expands Certified Public Cloud Infrastructure For SAP HANA

    Sep 12, 2017, 11:05 AM by Michael Croft

    Bio-IT World Brief | IBM today announced the availability of new SAP-certified bare metal servers for SAP HANA platform deployments in the IBM Cloud and new configurations for VMware environments. The new cloud infrastructure-as-a-service solutions are designed to give enterprises the power and performance they need to manage their mission-critical applications running on SAP HANA.

    Full story
  • Repositive Joins Campaign to Support Rare Disease

    Sep 12, 2017, 10:22 AM by Michael Croft
    CAMBRIDGE, UK - Sep 12, 2017 - ... Repositive, the company that created the world’s largest portal for accessing human genomic research data is using its data platform, community and influence to help Maddie Thurgood, a young girl from the UK with the rare disease, Spastic Paraplegia 15 (SPG15)
    Full story
  • Alexion Cutting 600 Jobs And Moving Headquarters In Major Shakeup

    Sep 12, 2017, 09:41 AM by Michael Croft
    STAT | Alexion, once one of biotech's biggest success stories, is eliminating 20% of its global workforce as it struggles to map out a brighter future.
    Full story
  • Recipharm and CTC launch integrated first in human service

    Sep 12, 2017, 05:40 AM by Michael Croft
    - Sep 12, 2017 - Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones
    Full story
  • Sam Beck, Ph.D., Joins MDI Biological Laboratory Faculty in Computational Biolog

    Sep 11, 2017, 11:15 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Sep 11, 2017 - The MDI Biological Laboratory has announced that Sam Beck, Ph.D., has joined the faculty as an assistant professor of computational biology
    Full story
  • ArisGlobal Announces LifeSphere Mobile MA™, Life Science’s First Multi-Function, Self-Service Portal for Medical Affairs and Pharmacovigilance

    Sep 11, 2017, 10:20 AM by Michael Croft
    MIAMI, FL, UNITED STATES - Sep 13, 2017 - ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences, today announced that LifeSphere Mobile MA™ is the first multi-lingual service portal and mobile app for medical affairs and pharmacovigilance to help sales reps, medical science liaisons (MSLs), healthcare professionals and even patients access approved product content, address adverse event management, and submit medical inquiries and product quality complaints from any mobile device
    Full story
  • Long-Read Sequencing Data Enables Structural Variant Discovery For Clinical And Disease Research

    Sep 11, 2017, 10:15 AM by Michael Croft

    Bio-IT World Contributed Commentary | The advent of single molecule, real-time sequencing, with average read lengths exceeding 12 kb, has allowed scientists to reliably detect structural variation for the first time. These latest studies have shown that previous human genome data sets have dramatically underrepresented the number of structural variants—along with their effect on health and disease.

    Full story
  • Ardena launches following Pharmavize and Crystallics merger

    Sep 11, 2017, 05:40 AM by Michael Croft
    - Sep 11, 2017 - A new early-phase contract development and manufacturing organisation (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics
    Full story
  • Amid Setback Researchers Forge Ahead with “Off-the-Shelf” Immune Cells to Treat Cancer

    Sep 8, 2017, 14:15 PM by Michael Croft
    MIT Technology Review | The approach could treat patients in dire need faster at a lower price, but major questions remain about safety.
    Full story
  • Genestack offers ‘missing link’ for genomics drug discovery

    Sep 8, 2017, 12:10 PM by Michael Croft
    CAMBRIDGE, UK - Sep 8, 2017 - “Genestack is providing an essential missing link between data and its analysis,” says Imad I. Yassin, recently appointed Vice President of Sales and Marketing for Genestack, the Cambridge-based biodata management company
    Full story
  • «
  • 311
  • 312 (current)
  • 313
  • 314
  • 315
  • 316
  • 317
  • 318
  • 319
  • 320
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy